Author Login

Correspondence to Author: Chen Jingyuan Xie, 

Department of Nephrology, Ruijin Hospital, and Institute of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai , China.

ABSTRACT: 
History: One type of clonal B-cell malignancy of the bone marrow is called multiple myeloma (MM). One common MM consequence is renal dysfunction. A systematic review of kidney illness caused by MM does not yet exist in China.
Synopsis: In China, there are 0.6 cases of MM per 100,000 people. Among all MM patients, renal insufficiency was seen in 24, 19.7, and 30.8%. [In Taiwan, Hong Kong, and the Chinese mainland, respectively, defined by serum creatinine (Scr) ≥ 2 mg/dl] at diagnosis. It is advised to use novel criteria for evaluating renal function in patients with MM who have stabilized Scr, which are based on estimated glomerular filtration rate findings.According to reports, 30.5% of MM patients had a creatinine clearance rate (Ccr) of less than 30 ml/min, while 78% of patients had a Ccr of less than 90 ml/ min.

Citation:

Chen Jingyuan Xie. The incidence and treatment of kidney disease caused by multiple myeloma in China. The American Journal of Kidney Diseases 2024.